Recent Updates
Recently added Catalysts
ELUT Positive Sentiment Score: 75/100

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

Thursday, February 20, 2025 1 min read
Key Takeaway: Elutia Inc. has announced that it will be reporting its fourth quarter and full year financial results for 2024 on March 6, 2025. The company, known for its drug-eluting biomatrix technologies, aims to improve medical device compatibility for patients. A conference call will follow the results announcement, allowing investors to engage with the management team. The event will also be available via a live and archived webcast on the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Elutia is set to release its financial results, indicating ongoing operations.
  • The company emphasizes a mission focused on improving patient outcomes.
  • A growing population in need of medical implants suggests market potential.

Full Press Release Details

SILVER SPRING, Md., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025. Members of the Company’s management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.
The conference call can be accessed using the following information:
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13751810
Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/.
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
matt.steinberg@finnpartners.com

Frequently Asked Questions

When will Elutia Inc. release its 2024 financial results?

Elutia Inc. will release its 2024 financial results on March 6, 2025.

What time is the Elutia conference call scheduled?

The Elutia conference call is set for 4:30 p.m. Eastern Time.

How can I access the Elutia conference call?

You can access the call at 877-407-8029 for U.S. investors.

Where can I find more information about Elutia?

More information can be found on Elutia's website at www.Elutia.com.

What is Elutia's mission?

Elutia aims to humanize medicine, helping patients thrive with implantable technologies.

Tags: ELUT Viatris Investor Conferences Healthcare financial results drug-eluting biomatrix conference call medical devices
Last updated: Feb 20, 2025